Published August 4, 2026 | Version v1

Emerging Role of Artificial Neural Networks in Pharmaceutical Sciences: From Drug Modelling to Formulation Optimization

Description

The technology known as artificial neural networks (ANNs) simulates the brain's neural networks' capacity for pattern recognition. An artificial neuron unit accepts inputs from a variety of external sources, evaluates them, and makes decisions, much like a single neuron in the brain. Artificial Neural Networks (ANNs) have proven to be highly beneficial in a variety of pharmaceutical research areas, such as brain neural network modelling, analytical data analysis, drug modelling, protein structure and function, dosage optimization and manufacturing, and pharmacokinetics. Because ANNs can replicate the brain's natural functioning, they are quickly becoming the preferred tool for the pharmaceutical industry. Modelling of pharmacodynamics and IVIVC correlation. The pharmaceutical sector is increasingly using Artificial Neural Networks (ANN) as their preferred tool because of their capacity to replicate how the brain works. The pharmaceutical industry has recently become interested in finding potential pharmaceutical items that meet all technical standards thanks to computational and statistical methodologies. Numerous neural network types have previously been created, and new ones are created every week. However, all of them may be characterized by the connection formula, learning rule, and transfer functions of their neurons. Particularly for data sets with nonlinear correlations, which are commonly seen in pharmaceutical operations, ANN is a viable modelling tool.

Files

21-Dara Harini.pdf

Files (4.4 MB)

Name Size
md5:256ff4a003031dd815a8d59437acd82f
4.4 MB Preview Download